Christopher Ritchie Mantyh
Professor of SurgeryOverview
Neurogenic inflammation
Ulcerative colitis
Crohn's disease
Neuropeptides
Receptors
Vanilloid receptor
Substance P
Intestinal motility
Colorectal cancer outcomes
Colon cancer
Rectal cancer
Positions
Professor of Surgery in the School of Medicine
2015 School of Medicine
Vice Chair of Clinical Operations in the School of Medicine
2023 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
1999 School of Medicine
Education
M.D., University of Wisconsin, Madison 1991
1991 University of Wisconsin, Madison
Resident, Duke University, Surgery 1991 - 1998
1998 Duke University
Publications, Grants & Awards
- Grants (8)
- Academics Articles (191)
- Conference Pages (97)
- Book Sections (4)
Showing 1 - 5 of 8
A Phase 3, Multicenter, Prospective, Randomized, Open-label Study for Intraoperative Ureter(s) Visualization When Using ASP5354 with Near-infrared Fluorescence (NIR-F) Imaging in Adult Participants Undergoing Minimally Invasive and Open Abdominopelvi
Astellas Pharma Global Development, Inc
Inhibition of CaMKK2 sensitizes rectal cancers to radiation therapy
National Institutes of Health
Prevention of Surgical Site Infection using Statistical Process Control Charts
Agency for Healthcare Research and Quality
A Randomized, Double-blind, Placebo Controlled Efficacy, Safety, and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery
Dr. Reddy's Laboratories Ltd.
Cancer Control Using Message Framing to Promote Physical Activity in Colorectal Cancer Survivors
National Institutes of Health
DCI Centers, Cancer Types & Labs
Offices & Contact
7676 Hosp North Hafs Building
Durham, NC
27710
Box 3117 Med Ctr
Durham, NC
27710